Yuhan Corporation (000105.KS), a pharmaceutical company, on Thursday reported first-quarter 2026 results with mixed performance, as revenue and operating income increased year on year, while profit before tax and net income declined.
Net income from continuing operation before income tax fell to 41.203 billion won from 43.426 billion won in the same period last year.
Operating income rose to 8.830 billion won, compared with 8.645 billion won a year earlier.
Net income declined 5% to 37.357 billion won from 39.331 billion won in the prior-year period.
Sales increased to 509.616 billion won from 469.412 billion won last year.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.